Browsing by Author "Folayan, Morenike O"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemOpen AccessAssociations between COVID-19 testing status, non-communicable diseases and HIV status among residents of sub-Saharan Africa during the first wave of the pandemic.(BMC Infectious Diseases, 2022-06-13T00:00:00Z) Folayan, Morenike O; Abeldaño Zuñiga, Roberto Ariel; Virtanen, Jorma I; El Tantawi, Maha; Abeldaño, Giuliana Florencia; Ishabiyi, Anthonia Omotola; Jafer, Mohammed; Al-Khanati, Nuraldeen Maher; Quadri, Mir Faeq Ali; Yousaf, Muhammad Abrar; Ellakany, Passent; Nzimande, Ntombifuthi; Ara, Eshrat; Khalid, Zumama; Lawal, Folake Barakat; Lusher, Joanne; Popoola, Bamidele O; Idigbe, Ifeoma; Khan, Abeedha Tu-Allah; Ayanore, Martin Amogre; Gaffar, Balgis; Osamika, Bamidele Emmanuel; Aly, Nourhan M; Ndembi, Nicaise; Nguyen, Annie LuThis study determined if non-communicable disease status, HIV status, COVID-19 status and co-habiting were associated with COVID-19 test status in sub-Saharan Africa. Data of 5945 respondents age 18-years-old and above from 31 countries in sub-Saharan Africa collected through an online survey conducted between June and December 2020, were extracted. The dependent variable was COVID-19 status (testing positive for COVID-19 and having symptoms of COVID-19 but not getting tested). The independent variables were non-communicable disease status (hypertension, diabetes, cancer, heart conditions, respiratory conditions, depression), HIV positive status, COVID-19 status (knowing a close friend who tested positive for COVID-19 and someone who died from COVID-19) and co-habiting (yes/no). Two binary logistic regression models developed to determine associations between the dependent and independent variables were adjusted for age, sex, employment, sub region and educational status. Having a close friend who tested positive for COVID-19 (AOR:6.747), knowing someone who died from COVID-19 infection (AOR:1.732), and living with other people (AOR:1.512) were significantly associated with higher odds of testing positive for COVID-19 infection, while living with HIV was associated with significantly lower odds of testing positive for COVID-19 infection (AOR:0.284). Also, respondents with respiratory conditions (AOR:2.487), self-reported depression (AOR:1.901), those who had a close friend who tested positive for COVID-19 infection (AOR:2.562) and who knew someone who died from COVID-19 infection (AOR:1.811) had significantly higher odds of having symptoms of COVID-19 infection but not getting tested. Non-communicable diseases seem not to increase the risk for COVID-19 positive test while cohabiting seems to reduce this risk. The likelihood that those who know someone who tested positive to or who died from COVID-19 not getting tested when symptomatic suggests there is poor contact tracing in the region. People with respiratory conditions and depression need support to get tested for COVID-19.
- ItemOpen AccessHIV prevention clinical trials' community engagement guidelines: inequality, and ethical conflicts.(Routledge Taylor and Francis group, 2020-06-05T00:00:00Z) Folayan, Morenike O; Peterson, KristinIn 2004 and 2005, the first clinical trials were launched to investigate the use of tenofovir for HIV prevention in Cambodia,Cameroon, Nigeria and Thailand. Controversies erupted over the ethical integrity of the research protocol. We reflect on the events that ledto the controversies and identified that scientific and ethical concerns raised by members of local communities at each of these sites wereerased by trialists, causing crisis that led to premature shut down the early PrEP trials. In the aftermath of these trials, the World HealthOrganisation, UNAIDS, and AVAC developed ethics guidelines intended to recognize the concerns as authentic, and developed guidelines toimprove researchers' engagement of communities in biomedical HIV prevention trial design and implementation. Our findings suggest thatthe ethics guidelines are limited in its ability to address power inequalities that leads to voice erasures and non-recognition of localcompetencies. Rather the ethical documents enabled trialists to gain a new sense of authority through the interpretations of ethical researchconduct enabling trialists regain power that can further entrench inequality and voice erasures. To address concerns with what seems anintractable problem, we suggested models of engagement for off-shored research may be the option.